These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11518471)

  • 1. Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors.
    Zullino D; Baumann P
    Pharmacopsychiatry; 2001 Jul; 34(4):119-27. PubMed ID: 11518471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium augmentation of antidepressants in treatment-refractory depression.
    Heit S; Nemeroff CB
    J Clin Psychiatry; 1998; 59 Suppl 6():28-33; discussion 34. PubMed ID: 9674934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
    Edwards SJ; Hamilton V; Nherera L; Trevor N
    Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is successful lithium augmentation limited to serotonergic antidepressants?
    Bschor T; Bauer M
    J Clin Psychopharmacol; 2004 Apr; 24(2):240-1; author reply 241-2. PubMed ID: 15206679
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of antidepressant nonresponders: augmentation or switch?
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 15():35-41. PubMed ID: 9786309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of serotonin selective reuptake inhibitors in geriatric depression.
    Newhouse PA
    J Clin Psychiatry; 1996; 57 Suppl 5():12-22. PubMed ID: 8647788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation strategies with serotonergic-noradrenergic combinations.
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
    Taylor D
    Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory depression: a review with particular reference to the use of lithium augmentation.
    Katona CL
    Eur Neuropsychopharmacol; 1995; 5 Suppl():109-13. PubMed ID: 8775769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
    Finley PR
    Ann Pharmacother; 1994 Dec; 28(12):1359-69. PubMed ID: 7696728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium augmentation of venlafaxine: an open-label trial.
    Hoencamp E; Haffmans J; Dijken WA; Huijbrechts IP
    J Clin Psychopharmacol; 2000 Oct; 20(5):538-43. PubMed ID: 11001238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
    Whyte EM; Basinski J; Farhi P; Dew MA; Begley A; Mulsant BH; Reynolds CF
    J Clin Psychiatry; 2004 Dec; 65(12):1634-41. PubMed ID: 15641868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium.
    Deligiannidis KM
    J Clin Psychiatry; 2010 May; 71(5):649-50. PubMed ID: 20492855
    [No Abstract]   [Full Text] [Related]  

  • 17. Lithium augmentation in sertraline-resistant depression: a preliminary dose-response study.
    Dinan TG
    Acta Psychiatr Scand; 1993 Oct; 88(4):300-1. PubMed ID: 8256650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What role do atypical antipsychotic drugs have in treatment-resistant depression?
    Thase ME
    J Clin Psychiatry; 2002 Feb; 63(2):95-103. PubMed ID: 11874227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians.
    Mischoulon D; Nierenberg AA; Kizilbash L; Rosenbaum JF; Fava M
    Can J Psychiatry; 2000 Jun; 45(5):476-81. PubMed ID: 10900529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment strategies in psychiatry.
    Nelson JC
    J Clin Psychiatry; 1993 Sep; 54 Suppl():42-9; discussion 55-6. PubMed ID: 8104933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.